ArticleClinical epigenetics2025

DOT1L inhibition exerts the anti-tumor effect by activating interferon signaling in breast cancer cells.

Ayano Yoshido et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.